BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bischoff J, Rockstroh JK. Are there any challenges left in hepatitis C virus therapy of HIV-infected patients? International Journal of Antimicrobial Agents 2020;56:105527. [DOI: 10.1016/j.ijantimicag.2018.08.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Castry M, Cousien A, Bellet J, Champenois K, Pialoux G, Yazdanpanah Y, Costagliola D, Grabar S, Deuffic-Burban S; French Hospital Database on HIV (ANRS CO4-FHDH Cohort). Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017. Euro Surveill 2021;26. [PMID: 34558403 DOI: 10.2807/1560-7917.ES.2021.26.38.2001321] [Reference Citation Analysis]
2 Dusheiko G, Childs K. Micro-elimination of HIV and HCV co-infection. Lancet HIV 2021;8:e61-2. [PMID: 33357836 DOI: 10.1016/S2352-3018(20)30303-9] [Reference Citation Analysis]
3 Oikonomou KG, Tsai E, Sarpel D, Dieterich DT. Liver Disease in Human Immunodeficiency Virus Infection. Clin Liver Dis 2019;23:309-29. [PMID: 30947879 DOI: 10.1016/j.cld.2018.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Ganesan M, Poluektova LY, Kharbanda KK, Osna NA. Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression. World J Gastroenterol 2019; 25(4): 398-410 [PMID: 30700937 DOI: 10.3748/wjg.v25.i4.398] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]